Firazyr Side Effects
Generic Name: icatibant
Note: This page contains information about the side effects of icatibant. Some of the dosage forms included on this document may not apply to the brand name Firazyr.
Common side effects of Firazyr include: hematoma at injection site, urticaria at injection site, injection site reaction, pain at injection site, irritation at injection site, erythema at injection site, swelling at injection site, burning sensation at injection site, and bruising at injection site. See below for a comprehensive list of adverse effects.
For the Consumer
Applies to icatibant: subcutaneous solution
In addition to its needed effects, some unwanted effects may be caused by icatibant (the active ingredient contained in Firazyr). In the event that any of these side effects do occur, they may require medical attention.
You should check with your doctor immediately if any of these side effects occur when taking icatibant:Less common:
Some of the side effects that can occur with icatibant may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional:More common:
- Bleeding, blistering, burning, coldness, discoloration of the skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site
For Healthcare Professionals
Applies to icatibant: subcutaneous solution
The most common adverse reactions were injection site reactions, pyrexia, transaminase increased, dizziness, and rash.[Ref]
Injection site reaction includes bruising, hematoma, burning, erythema, hypoesthesia, irritation, numbness, edema, pain, pressure sensation, pruritus, swelling, urticaria, or warmth at the site of injection.[Ref]
Very common (10% or more): Injection site reaction (97%)[Ref]
Common (1% to 10%): Rash, pruritus, erythema
Uncommon (0.1% to 1%): Generalized urticaria[Ref]
Common (1% to 10%): Nasopharyngitis, nasal congestion
Uncommon (0.1% to 1%): Pharyngitis, asthma, cough[Ref]
Common (1% to 10%): Gastroenteritis, nausea
Uncommon (0.1% to 1%): Vomiting[Ref]
Common (1% to 10%): Dizziness, headache[Ref]
Common (1% to 10%): Pyrexia
Uncommon (0.1% to 1%): Asthenia, fatigue, contusion[Ref]
Common (1% to 10%): Transaminase increased
Uncommon (0.1% to 1%): Liver function test abnormal[Ref]
Common (1% to 10%): Prothrombin time prolonged[Ref]
Common (1% to 10%): Blood creatinine phosphokinase increased[Ref]
Uncommon (0.1% to 1%): Weight increased, blood glucose increased, hyperuricemia, hyperglycemia[Ref]
Uncommon (0.1% to 1%): Herpes zoster
Frequency not reported: Anti-icatibant (the active ingredient contained in Firazyr) antibodies[Ref]
Uncommon (0.1% to 1%): Hot flush[Ref]
Uncommon (0.1% to 1%): Proteinuria[Ref]
Uncommon (0.1% to 1%): Muscle spasm[Ref]
1. Cerner Multum, Inc. "Australian Product Information." O 0
2. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
3. "Product Information. Firazyr (icatibant)." Shire US Inc, Florence, KY.
Not all side effects for Firazyr may be reported. You should always consult a doctor or healthcare professional for medical advice. Side effects can be reported to the FDA here.
More about Firazyr (icatibant)
Related treatment guides
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate safety, effectiveness, or appropriateness for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of materials provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the substances you are taking, check with your doctor, nurse, or pharmacist.